157 related articles for article (PubMed ID: 23233739)
21. Development of a Bioluminescent Nitroreductase Probe for Preclinical Imaging.
Vorobyeva AG; Stanton M; Godinat A; Lund KB; Karateev GG; Francis KP; Allen E; Gelovani JG; McCormack E; Tangney M; Dubikovskaya EA
PLoS One; 2015; 10(6):e0131037. PubMed ID: 26110789
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of human fetal bone implants in SCID mice as a model of prostate cancer bone metastasis.
Singh AS; Macpherson GR; Price DK; Schimel D; Figg WD
Oncol Rep; 2006 Mar; 15(3):519-24. PubMed ID: 16465406
[TBL] [Abstract][Full Text] [Related]
23. Mechanism of CB1954 reduction by Escherichia coli nitroreductase.
Christofferson A; Wilkie J
Biochem Soc Trans; 2009 Apr; 37(Pt 2):413-8. PubMed ID: 19290872
[TBL] [Abstract][Full Text] [Related]
24. NTR 2.0: a rationally engineered prodrug-converting enzyme with substantially enhanced efficacy for targeted cell ablation.
Sharrock AV; Mulligan TS; Hall KR; Williams EM; White DT; Zhang L; Emmerich K; Matthews F; Nimmagadda S; Washington S; Le KD; Meir-Levi D; Cox OL; Saxena MT; Calof AL; Lopez-Burks ME; Lander AD; Ding D; Ji H; Ackerley DF; Mumm JS
Nat Methods; 2022 Feb; 19(2):205-215. PubMed ID: 35132245
[TBL] [Abstract][Full Text] [Related]
25. Engineering
Williams EM; Rich MH; Mowday AM; Ashoorzadeh A; Copp JN; Guise CP; Anderson RF; Flanagan JU; Smaill JB; Patterson AV; Ackerley DF
Biochemistry; 2019 Sep; 58(35):3700-3710. PubMed ID: 31403283
[TBL] [Abstract][Full Text] [Related]
26. Escherichia coli nitroreductase plus CB1954 enhances the effect of radiotherapy in vitro and in vivo.
White CL; Menghistu T; Twigger KR; Searle PF; Bhide SA; Vile RG; Melcher AA; Pandha HS; Harrington KJ
Gene Ther; 2008 Mar; 15(6):424-33. PubMed ID: 18079753
[TBL] [Abstract][Full Text] [Related]
27. Orthotopic metastatic (MetaMouse) models for discovery and development of novel chemotherapy.
Hoffman RM
Methods Mol Med; 2005; 111():297-322. PubMed ID: 15911987
[TBL] [Abstract][Full Text] [Related]
28. Imaging and quantification of metastatic melanoma cells in lymph nodes with a ferritin MR reporter in living mice.
Choi SH; Cho HR; Kim HS; Kim YH; Kang KW; Kim H; Moon WK
NMR Biomed; 2012 May; 25(5):737-45. PubMed ID: 22124937
[TBL] [Abstract][Full Text] [Related]
29. Enhanced cell-specific ablation in zebrafish using a triple mutant of Escherichia coli nitroreductase.
Mathias JR; Zhang Z; Saxena MT; Mumm JS
Zebrafish; 2014 Apr; 11(2):85-97. PubMed ID: 24428354
[TBL] [Abstract][Full Text] [Related]
30. In vivo optical imaging of acute myeloid leukemia by green fluorescent protein: time-domain autofluorescence decoupling, fluorophore quantification, and localization.
McCormack E; Micklem DR; Pindard LE; Silden E; Gallant P; Belenkov A; Lorens JB; Gjertsen BT
Mol Imaging; 2007; 6(3):193-204. PubMed ID: 17532885
[TBL] [Abstract][Full Text] [Related]
31. Dual probe with fluorescent and magnetic properties for imaging solid tumor xenografts.
Shan L; Wang S; Sridhar R; Bhujwalla ZM; Wang PC
Mol Imaging; 2007; 6(2):85-95. PubMed ID: 17445503
[TBL] [Abstract][Full Text] [Related]
32. The expression of bacterial nitroreductase in transgenic mice results in specific cell killing by the prodrug CB1954.
Drabek D; Guy J; Craig R; Grosveld F
Gene Ther; 1997 Feb; 4(2):93-100. PubMed ID: 9081711
[TBL] [Abstract][Full Text] [Related]
33. Catheter-based in vivo imaging of enzyme activity and gene expression: feasibility study in mice.
Funovics MA; Weissleder R; Mahmood U
Radiology; 2004 Jun; 231(3):659-66. PubMed ID: 15163807
[TBL] [Abstract][Full Text] [Related]
34. Selective ablation of human cancer cells by telomerase-specific adenoviral suicide gene therapy vectors expressing bacterial nitroreductase.
Bilsland AE; Anderson CJ; Fletcher-Monaghan AJ; McGregor F; Evans TR; Ganly I; Knox RJ; Plumb JA; Keith WN
Oncogene; 2003 Jan; 22(3):370-80. PubMed ID: 12545158
[TBL] [Abstract][Full Text] [Related]
35. Tumour-specific therapeutic adenovirus vectors: repression of transgene expression in healthy cells by endogenous p53.
Lipinski KS; Djeha AH; Krausz E; Lane DP; Searle PF; Mountain A; Wrighton CJ
Gene Ther; 2001 Feb; 8(4):274-81. PubMed ID: 11313801
[TBL] [Abstract][Full Text] [Related]
36. Near-infrared off-on fluorescence probe activated by NTR for in vivo hypoxia imaging.
Zheng J; Shen Y; Xu Z; Yuan Z; He Y; Wei C; Er M; Yin J; Chen H
Biosens Bioelectron; 2018 Nov; 119():141-148. PubMed ID: 30125874
[TBL] [Abstract][Full Text] [Related]
37. Nitroreductase-mediated cell ablation in transgenic zebrafish embryos.
Pisharath H; Parsons MJ
Methods Mol Biol; 2009; 546():133-43. PubMed ID: 19378102
[TBL] [Abstract][Full Text] [Related]
38. In vivo bacterial imaging without engineering; A novel probe-based strategy facilitated by endogenous nitroreductase enzymes.
Stanton M; Cronin M; Lehouritis P; Tangney M
Curr Gene Ther; 2015; 15(3):277-88. PubMed ID: 25619884
[TBL] [Abstract][Full Text] [Related]
39. Semiautomatic landmark-based two-dimensional-three-dimensional image fusion in living mice: correlation of near-infrared fluorescence imaging of Cy5.5-labeled antibodies with flat-panel volume computed tomography.
Dullin C; Zientkowska M; Napp J; Missbach-Guentner J; Krell HW; Müller F; Grabbe E; Tietze LF; Alves F
Mol Imaging; 2009; 8(1):2-14. PubMed ID: 19344571
[TBL] [Abstract][Full Text] [Related]
40. CD44 antibody-targeted liposomal nanoparticles for molecular imaging and therapy of hepatocellular carcinoma.
Wang L; Su W; Liu Z; Zhou M; Chen S; Chen Y; Lu D; Liu Y; Fan Y; Zheng Y; Han Z; Kong D; Wu JC; Xiang R; Li Z
Biomaterials; 2012 Jul; 33(20):5107-14. PubMed ID: 22494888
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
